306 related articles for article (PubMed ID: 28508950)
21. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.
Chow WH; Gridley G; Mellemkjaer L; McLaughlin JK; Olsen JH; Fraumeni JF
Cancer Causes Control; 1995 Jan; 6(1):9-13. PubMed ID: 7718740
[TBL] [Abstract][Full Text] [Related]
22. Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I; Fernández Castro M; Andreu JL; Sanchez-Piedra C; Martínez-Taboada V; Olivé A; López-Longo J; Rosas J; Galindo M; Calvo-Alén J; Fernández-Nebro A; Alonso F; Rodríguez-Lozano B; Alberto García Vadillo J; Menor R; Narváez FJ; Erausquin C; García-Aparicio Á; Tomero E; Manrique-Arija S; Horcada L; Uriarte E; Gil S; Blanco R; López-González R; Boteanu A; Freire M; Galisteo C; Rodríguez-Gómez M; Díez-Álvarez E; Pego-Reigosa JM;
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):38-45. PubMed ID: 27564390
[TBL] [Abstract][Full Text] [Related]
23. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study.
See LC; Kuo CF; Chou IJ; Chiou MJ; Yu KH
Semin Arthritis Rheum; 2013 Dec; 43(3):381-6. PubMed ID: 23916348
[TBL] [Abstract][Full Text] [Related]
24. Malignancies associated with systemic sclerosis.
Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study.
Lin TM; Chen WS; Sheu JJ; Chen YH; Chen JH; Chang CC
PLoS One; 2018; 13(1):e0186475. PubMed ID: 29304089
[TBL] [Abstract][Full Text] [Related]
26. The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis.
Lee H
Yonsei Med J; 2019 Feb; 60(2):223-229. PubMed ID: 30666845
[TBL] [Abstract][Full Text] [Related]
27. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.
Chen YJ; Wu CY; Huang YL; Wang CB; Shen JL; Chang YT
Arthritis Res Ther; 2010; 12(2):R70. PubMed ID: 20398365
[TBL] [Abstract][Full Text] [Related]
28. Association Between a History of Dengue Fever and the Risk of Systemic Autoimmune Rheumatic Diseases: A Nationwide, Population-Based Case-Control Study.
Chen YW; Hsieh TY; Lin CH; Chen HM; Lin CC; Chen HH
Front Med (Lausanne); 2021; 8():738291. PubMed ID: 34805205
[No Abstract] [Full Text] [Related]
29. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
30. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
31. Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China.
Chen D; Yuan S; Wu X; Li H; Qiu Q; Zhan Z; Ye Y; Lian F; Liang L; Xu H; Yang X
Clin Exp Rheumatol; 2014; 32(5):615-21. PubMed ID: 25068842
[TBL] [Abstract][Full Text] [Related]
32. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.
Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S
Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453
[TBL] [Abstract][Full Text] [Related]
33. Hematological malignancy associated with polymyositis and dermatomyositis.
Marie I; Guillevin L; Menard JF; Hatron PY; Cherin P; Amoura Z; Cacoub P; Bachelez H; Buzyn A; Le Roux G; Ziza JM; Brice P; Munck JN; Sarrot-Reynauld F; Piette JC; Larroche C
Autoimmun Rev; 2012 Jul; 11(9):615-20. PubMed ID: 22079677
[TBL] [Abstract][Full Text] [Related]
34. Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases.
Nozaki Y; Kinoshita K; Ri J; Sakai K; Shiga T; Hino S; Hirooka Y; Sugiyama M; Funauchi M; Matsumura I
Mod Rheumatol; 2016; 26(2):265-70. PubMed ID: 26360624
[TBL] [Abstract][Full Text] [Related]
35. Malignancy and autoimmunity.
Bernatsky S; Ramsey-Goldman R; Clarke A
Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
[TBL] [Abstract][Full Text] [Related]
36. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF
Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620
[TBL] [Abstract][Full Text] [Related]
37. The risk of cancer in patients with connective tissue diseases but without dermatomyositis or polymyositis: A multicenter cohort study conducted over 15 years in China.
Xu W; Guo H; Liu Z; Chen C; Lei CC
Immunol Lett; 2016 Sep; 177():70-4. PubMed ID: 27474413
[TBL] [Abstract][Full Text] [Related]
38. [Tumors in rheumatic diseases].
Świerkot J; Lewandowicz-Uszyńska A; Bogunia-Kubik K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1254-60. PubMed ID: 24379265
[TBL] [Abstract][Full Text] [Related]
39. Elevated cancer incidence in patients with dermatomyositis: a population based study.
Airio A; Pukkala E; Isomäki H
J Rheumatol; 1995 Jul; 22(7):1300-3. PubMed ID: 7562762
[TBL] [Abstract][Full Text] [Related]
40. Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study.
Chung MK; Lee CH; Park JS; Lim H; Lee J
Korean J Intern Med; 2022 Nov; 37(6):1250-1259. PubMed ID: 34233434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]